2022-RA-1136-ESGO A single-cell map of rare ovarian cancer
Laga, Tina, Busschaert, Pieter, Olbrecht, Siel, Loverix, Liselore, Lodi, Francesca, Baert, Thaïs, Gorp, Toon Van, Rompuy, Anne-Sophie Van, Vergote, Ignace, Lambrechts, Diether, Nieuwenhuysen, Els Van
Published in International journal of gynecological cancer (20.10.2022)
Published in International journal of gynecological cancer (20.10.2022)
Get full text
Journal Article
2022-RA-1473-ESGO Randomized phase II CLIO study on olaparib monotherapy versus chemotherapy in recurrent ovarian cancer – results of the Leuven HRD test
Loverix, Liselore, Vergote, Ignace, Vanderstichele, Adriaan, Busschaert, Pieter, Boeckx, Bram, Venken, Tom, van Nieuwenhuysen, Els, Baert, Thaïs, Han, Sileny, Neven, Patrick, Berteloot, Patrick, Olbrecht, Siel, Laga, Tina, Lambrechts, Diether, van Gorp, Toon
Published in International journal of gynecological cancer (20.10.2022)
Published in International journal of gynecological cancer (20.10.2022)
Get full text
Journal Article
2022-RA-1074-ESGO AGO-OVAR 2.29 (ENGOT-ov34): atezolizumab in combination with bevacizumab and chemotherapy vs bevacizumab and chemotherapy in recurrent ovarian cancer
Harter, Philipp, Marmé, Frederik, Pietzner, Klaus, Reuss, Alexander, Ray-Coquard, Isabelle, Redondo, Andrés, Oaknin, Ana, Jonuskiene, Goda, Lindemann, Kristina, Kurzeder, Christian, Huober, Jens, van Nieuwenhuysen, Els, Henry, Stephanie, Marth, Christian, Tsibulak, Irina, Cron, Nadin, Pautier, Patricia
Published in International journal of gynecological cancer (20.10.2022)
Published in International journal of gynecological cancer (20.10.2022)
Get full text
Journal Article
685 European multi-disciplinary tumour boards within the EURACAN network increasingly support management of patients with rare gynaecological tumours: results from 2017–2023 activity
Bergamini, Alice, Joneborg, Ulrika, Marquina, Gloria, Grassi, Elisa, Wallin, Emelie, Casado, Antonio, Solheim, Olesia, Sassu, Carolina Maria, Lok, Christianne AR, Bini, Marta, Pautier, Patricia, Kridelka, Frédéric, Sehouli, Jalid, Nieuwenhuysen, Els Van, Coulter, John, Bolze, Pierre-Adrien, Lebreton, Coriolan, Piek, Jurgen MJ, Ray-Coquard, Isabelle, Seckl, Michael
Published in International journal of gynecological cancer (10.03.2024)
Published in International journal of gynecological cancer (10.03.2024)
Get full text
Journal Article
237 InnovaTV 301/ENGOT-Cx12/GOG-3057: a global, randomized, open-label, phase 3 study of tisotumab vedotin versus investigator’s choice of chemotherapy in 2L Or 3L recurrent or metastatic cervical cancer
Martín, Antonio Gonzalez, Slomovitz, Brian M, Fujiwara, Keiichi, Kalbacher, Elsa, Bagameri, Andrea, Ghamande, Sharad, Lee, Jung-Yun, Banerjee, Susana, Maluf, Fernando, Lorusso, Domenica, Yonemori, Kan, Nieuwenhuysen, Els Van, Sánchez, Luis Manso, Woelber, Linn, Westermann, Anneke, Covens, Allan, Whalley, Elizabeth, Leng Teng, Melinda Siew, Soumaoro, Ibrahima, Vergote, Ignace
Published in International journal of gynecological cancer (10.03.2024)
Published in International journal of gynecological cancer (10.03.2024)
Get full text
Journal Article
1200 The significance of CTNNB1 mutation in endometrial cancer
Tuerlinckx, Charlotte, Bempt, Isabelle Vanden, Rompuy, Anne-Sophie Van, Baert, Thaïs, Amant, Fréderic, Olbrecht, Siel, Putte, Toon Van De, Nieuwenhuysen, Els Van, Gorp, Toon Van
Published in International journal of gynecological cancer (10.03.2024)
Published in International journal of gynecological cancer (10.03.2024)
Get full text
Journal Article
569 The Leuven PARPi benefit test as improved approach for prediction of PARPi benefit in the PAOLA-1/ENGOTov25 trial
Loverix, Liselore, Vergote, Ignace, Busschaert, Pieter, Venken, Tom, Harter, Philipp, Nieuwenhuysen, Els Van, Pignata, Sandro, Baert, Thaïs, Gonzalez-Martin, Antonio, Han, Sileny, Marth, Christian, Neven, Patrick, Colombo, Nicoletta, Putte, Toon Van De, Berteloot, Patrick, Mäenpäa, Johanna, Ray-Coquard, Isabelle, Pujade-Lauraine, Eric, Lambrechts, Diether, Gorp, Toon Van
Published in International journal of gynecological cancer (10.03.2024)
Published in International journal of gynecological cancer (10.03.2024)
Get full text
Journal Article
GOG-3097/ENGOT-ov81/GTG-UK/RAMP 301: a phase 3, randomized trial evaluating avutometinib plus defactinib compared with investigator’s choice of treatment in patients with recurrent low grade serous ovarian cancer
Grisham, Rachel, Monk, Bradley J, Van Nieuwenhuysen, Els, Moore, Kathleen Nadine, Fabbro, Michel, O’Malley, David M, Oaknin, Ana, Thaker, Premal, Oza, Amit M, Colombo, Nicoletta, Gershenson, David, Aghajanian, Carol A, Choi, Chel Hun, Lee, Yeh Chen, Mirza, Mansoor Raza, Coleman, Robert L, Cobb, Lauren, Harter, Philipp, Lustgarten, Stephanie, Youssoufian, Hagop, Banerjee, Susana
Published in International journal of gynecological cancer (07.10.2024)
Published in International journal of gynecological cancer (07.10.2024)
Get full text
Journal Article
PO011LBA/#1512 Ubamatamab (MUC16XCD3 bispecific antibody) with or without cemiplimab (Anti-PD-1 antibody) in recurrent ovarian cancer: phase 1 clinical and biomarker results
Liu, Joyce, O’Malley, David, Nieuwenhuysen, Els Van, Moore, Kathleen, Hamilton, Erika, Yeku, Oladapo, Bouberhan, Sara, Hou, June, Schröder, David, Wang, Bin, Yoo, Suk-Young, Govindraj, Shilpa, Brouwer-Visser, Jurriaan, Peterman, Mary, Schmidt, Tamara, Barnes, Brigid, Lowy, Israel, Uldrick, Thomas, Miller, Elizabeth, O’Cearbhaill, Roisin
Published in International journal of gynecological cancer (07.11.2023)
Published in International journal of gynecological cancer (07.11.2023)
Get full text
Journal Article
TP020/#1513 First-in-human phase 1/2 study of ubamatamab, a MUC16XCD3 bispecific antibody, administered alone or in combination with cemiplimab in patients with recurrent ovarian cancer
Moore, Kathleen, Bouberhan, Sara, Hamilton, Erika, Liu, Joyce, O’Cearbhaill, Roisin, O’Malley, David, Papadimitriou, Konstantinos, Schröder, David, Nieuwenhuysen, Els Van, Yoo, Suk-Young, Wang, Bin, Peterman, Mary, Gonçalves, Priscila, Schmidt, Tamara, Zhu, Min, Lowy, Israel, Uldrick, Thomas, Miller, Elizabeth
Published in International journal of gynecological cancer (07.11.2023)
Published in International journal of gynecological cancer (07.11.2023)
Get full text
Journal Article
PO004LBA/#1515 Efficacy and safety of avutometinib + defactinib in recurrent low-grade serous ovarian cancer following prior systemic therapy
Grisham, Rachel, Aghajanian, Carol, Nieuwenhuysen, Els Van, Rodrigues, Manuel, Ring, Kari, Santin, Alessandro, Colombo, Nicoletta, Prendergast, Emily, Thaker, Premal, Moore, Kathleen, Salinas, Erin, Ray-Coquard, Isabelle, Chon, Hye Sook, Rose, Peter, Oaknin, Ana, Clamp, Andrew, Gandhi, Mitul, Monk, Bradley, Holloway, Robert, Gorp, Toon Van, Fabbro, Michel, Gennigens, Christine, Wojtynek, Nicholas, Lustgarten, Stephanie, Banerjee, Susana
Published in International journal of gynecological cancer (01.11.2023)
Published in International journal of gynecological cancer (01.11.2023)
Get full text
Journal Article
Web Resource
Concordance between results of inexpensive statistical models and multigene signatures in patients with ER+/HER2− early breast cancer
Slembrouck, Laurence, Vanden Bempt, Isabelle, Wildiers, Hans, Smeets, Ann, Van Rompuy, Anne-Sophie, Van Ongeval, Chantal, Jongen, Lynn, Weltens, Caroline, Punie, Kevin, Hoste, Griet, Van Nieuwenhuysen, Els, Han, Sileny, Nevelsteen, Ines, Neven, Patrick, Floris, Giuseppe
Published in Modern pathology (01.07.2021)
Published in Modern pathology (01.07.2021)
Get full text
Journal Article
Integrative Kinome Profiling Identifies mTORC1/2 Inhibition as Treatment Strategy in Ovarian Clear Cell Carcinoma
Caumanns, Joseph J, Berns, Katrien, Wisman, G Bea A, Fehrmann, Rudolf S N, Tomar, Tushar, Klip, Harry, Meersma, Gert J, Hijmans, E Marielle, Gennissen, Annemiek M C, Duiker, Evelien W, Weening, Desiree, Itamochi, Hiroaki, Kluin, Roelof J C, Reyners, Anna K L, Birrer, Michael J, Salvesen, Helga B, Vergote, Ignace, van Nieuwenhuysen, Els, Brenton, James, Braicu, E Ioana, Kupryjanczyk, Jolanta, Spiewankiewicz, Beata, Mittempergher, Lorenza, Bernards, René, van der Zee, Ate G J, de Jong, Steven
Published in Clinical cancer research (15.08.2018)
Published in Clinical cancer research (15.08.2018)
Get full text
Journal Article
619 Durvalumab plus carboplatin/paclitaxel followed by durvalumab ± olaparib as a first-line treatment for newly diagnosed advanced or recurrent endometrial cancer: results from the phase III DUO-E/GOG-3041/ENGOT-EN10 Trial
Westin, Shannon N, Moore, Kathleen N, Chon, Hye Sook, Lee, Jung-Yun, Pepin, Jessica Thomes, Sundborg, Michael, Garza, Joseph De La, Nishio, Shin, Wang, Ke, Mcintyre, Kristi, Tillmanns, Todd D, Mejia, Fernando Contreras, Melo, Andreia Cristina De, Klasa-Mazurkewicz, Dagmara, Papadimitriou, Christos, Gil-Martin, Marta, Brasiuniene, Birute, Donnelly, Conor, Liu, Xiaochun, Nieuwenhuysen, Els Van
Published in International journal of gynecological cancer (10.03.2024)
Published in International journal of gynecological cancer (10.03.2024)
Get full text
Journal Article
Positive DESKTOP and Tian Scores Systems Are Adequate to Predict Optimal (R0) Secondary Debulking Surgery in Ovarian Cancer, But a Negative Score Does Not Preclude Secondary Surgery
Laga, Tina, Lambrechts, Sandrina, Laenen, Annouschka, Van Nieuwenhuysen, Els, Han, Sileny N, Vergote, Ignace
Published in International journal of gynecological cancer (01.05.2018)
Published in International journal of gynecological cancer (01.05.2018)
Get full text
Journal Article
2022-RA-1392-ESGO Tisotumab vedotin combinations with pembrolizumab or carboplatin in patients with recurrent/metastatic cervical cancer: interim results of ENGOT Cx8/GOG-3024/innovaTV205
Lorusso, Domenica, Vergote, Ignace, O’Cearbhaill, Roisin E, Westermann, Anne M, Banerjee, Susana, van Nieuwenhuysen, Els, Iglesias, David A, Collins, Dearbhaile, Cibula, David, Madsen, Kristine, Tewari, Krishnansu S, Pignata, Sandro, Baurain, Jean-Francois, Boere, Ingrid A, Denys, Hannelore, Andreassen, Camilla Mondrup, Soumaoro, Ibrahima, Jain, Shweta, Gennigens, Christine, Monk, Bradley J
Published in International journal of gynecological cancer (20.10.2022)
Published in International journal of gynecological cancer (20.10.2022)
Get full text
Journal Article
2022-RA-883-ESGO Rare Cancers in Gynecologic Oncology, ENGOT initiative for a European Registry
Ceppi, Lorenzo, Bergamini, Alice, Biagioli, Elena, Solheim, Olesya, González-Martín, Antonio, Ottevanger, Nelleke, van Nieuwenhuysen, Els, Hasenburg, Annette, Cadoo, Karen, Braicu, Elena Ioana, Hall, Marcia, Bauerschlag, Dirk, Aust, Stefanie, Glasspool, Ross, Lok, Christianne, Korach, Jacob, Cibula, David, Pignata, Sandro, Ray-Coquard, Isabel
Published in International journal of gynecological cancer (20.10.2022)
Published in International journal of gynecological cancer (20.10.2022)
Get full text
Journal Article
2022-RA-1263-ESGO Phase II randomized BGOG-CX3 trial comparing atezolizumab in combination with doxorubicin versus doxorubicin alone in second-line or later recurrent cervical cancer
Loverix, Liselore, Salihi, Rawand, van Rompuy, Anne-Sophie, Vanderstichele, Adriaan, van Nieuwenhuysen, Els, Baert, Thaïs, Debruyne, Philip, Cornez, Nathalie, Henry, Stéphanie, Neven, Patrick, Han, Sileny, Berteloot, Patrick, Olbrecht, Siel, Laga, Tina, Busschaert, Pieter, van Gorp, Toon, Vergote, Ignace
Published in International journal of gynecological cancer (20.10.2022)
Published in International journal of gynecological cancer (20.10.2022)
Get full text
Journal Article
2022-RA-324-ESGO Phase 2 results from the LIO-1 STUDY (NCT04042116; ENGOT-GYN3/AGO/LIO): efficacy and safety of lucitanib + nivolumab in patients with advanced gynaecological malignancies
Concin, Nicole, Patel, Manish R, Makker, Vicky, Oaknin, Ana, Pignata, Sandro, Backes, Floor J, González-Martín, Antonio, Eskander, Ramez N, Pothuri, Bhavana, Richardson, Debra L, Secord, Angeles Alvarez, van Nieuwenhuysen, Els, Liu, Joyce F, Musa, Fernanda, Penson, Richard T, Wride, Kenton, Dusek, Rachel, Cameron, Terri, Hamilton, Erika
Published in International journal of gynecological cancer (20.10.2022)
Published in International journal of gynecological cancer (20.10.2022)
Get full text
Journal Article